Emerald Advisers’s Patterson-UTI PTEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-49,949
Closed -$700K 264
2019
Q1
$700K Sell
49,949
-67,636
-58% -$887K 0.03% 188
2018
Q4
$1.22M Sell
117,585
-1,543
-1% -$22.7K 0.06% 141
2018
Q3
$2.04M Buy
119,128
+44,719
+60% +$768K 0.07% 135
2018
Q2
$1.34M Buy
74,409
+31,061
+72% +$623K 0.05% 162
2018
Q1
$759K Buy
43,348
+32,839
+312% +$686K 0.03% 198
2017
Q4
$242K Buy
+10,509
New +$218K 0.01% 231
2017
Q2
Sell
-68,086
Closed -$1.65M 244
2017
Q1
$1.65M Buy
68,086
+49,426
+265% +$1.33M 0.07% 163
2016
Q4
$502K Buy
+18,660
New +$461K 0.02% 204
2014
Q4
Sell
-83,795
Closed -$2.73M 353
2014
Q3
$2.73M Buy
83,795
+1,681
+2% +$57.1K 0.16% 174
2014
Q2
$2.87M Buy
82,114
+52,130
+174% +$1.71M 0.16% 171
2014
Q1
$950K Buy
+29,984
New +$834K 0.05% 253

Other funds holding PTEN

Emerald Advisers's PTEN Position: Q2 2019 in Review

Emerald Advisers sold out of Patterson-UTI (PTEN) in Q2 2019, closing a stake of 49,949 shares — an estimated $700K sold.

Emerald Advisers first reported a position in PTEN in Q1 2014 and held it in 11 quarters. The position peaked at $2.87M in Q2 2014. 278 funds tracked by Wall St. Rank hold PTEN as of Q2 2019.

  • Emerald Advisers reported no remaining Patterson-UTI position as of Q2 2019 after selling out during the quarter.
  • Emerald Advisers sold 49,949 Patterson-UTI shares in Q2 2019, an estimated $700K.
  • Emerald Advisers first reported a position in Patterson-UTI in Q1 2014 and held it in 11 quarters.
  • Emerald Advisers's Patterson-UTI position peaked at $2.87M in Q2 2014.
  • 278 funds tracked by Wall St. Rank held Patterson-UTI as of Q2 2019.

Based on Emerald Advisers's 13F filing for Q2 2019, filed 31 Jul 2019.